Formation Bio CEO Ben Liu on Fixing the Bottleneck Slowing Down Medicine
Inside the ICE House
•
19m
Formation Bio is rewriting the rules of drug development at a time when AI is accelerating drug discovery far faster than the industry can bring new therapies to patients. CEO Ben Liu goes Inside the ICE House to explain why the real bottleneck in pharma isn't finding promising drug candidates, it's developing them efficiently and at scale. He unpacks Formation Bio's AI-native model, which acquires already-discovered drugs and deploys proprietary tools to optimize trial design, predict clinical outcomes, and identify overlooked disease indications.
Up Next in Inside the ICE House
-
Howard Hughes Corp. CEO David O'Reill...
David O’Reilly, CEO of the Howard Hughes Corporation (NYSE: HHC), lives and works in The Woodlands, a LEED-certified master planned community that’s part of his company’s portfolio of 118,000 acres of real estate. O’Reilly is a familiar face around Wall Street thanks to projects like the Tin Buil...
-
Workiva's Mike Rost & Mandi McReynold...
Workiva is reshaping how companies approach ESG and financial transparency through innovation, integration, and trust. Mike Rost and Mandi McReynolds go Inside the ICE House to share how the company’s unified platform is empowering organizations to deliver investor-grade disclosures with confiden...
-
America's Longest-Held POW: Author Ba...
Shot down during on a covert CIA mission over China in 1952, Jack Downey endured over two decades of imprisonment in Communist hands. Through consistent routines and mental discipline that enhanced his value to his captors, Downey maintained hope and optimism that he would one day be liberated. E...
